Replies to post #8249 on Hemispherx BioPharma (HEB)

[softballdaddy]

Those unknowns is why I play the runup and will only hold free shares into catalyst itself

Nice read

[JohnnyD3]

Right. Because anyone with a contrarian review must be a sociopath.

I'm not talking contrarian views, I'm talking about shorting promising small biotechs, which develop drugs to relieve human suffering, for money. Because of low capitalization and long and expensive drug development times, biotechs are vulnerable to unscrupulous hedge funds who hold the stock both long and short in order to manipulate the stock for financial gain... often at the cost of human suffering. It should be illegal. I won't even get into the bashing done on Alferon-N, an already approved FDA drug. So yes, you, Adam F. and all your buddies who short and manipulate HEB stock do indeed fit to a "T" the definition of a sociopath.

You pay lip service to the FDA, "if it works, Ampligen should be approved"... blah blah. But the fact is that HEB has had limited marketing approval for Ampligen since 1997 under compassionate care (the AMP511 cost recovery trial). the drug has been given, in high doses, (90,000 doses) to 1000 patients over the years. The safety record is good, the P value on efficacy is good, there are a number of peer reviewed papers that show benefit to QT interval, VO2max, life functioning, etc. Yet, assholes with political science degrees, write very deceptive articles to declare that the drug will never get approved... while patients suffer because of limited access. And they work hard at the deception. Why? to line your/their greedy little pockets.

I don't expect this post to sway you in the least, or when ampligen gets approved next year, I don't expect any regret from you, Adam or the rest of the hedge fund that has been manipulating the stock (other than Adam's pat answer of Gee, I was wrong, let's move along). After all, regret and empathy are things sociopaths are incapable of.

Have a good day.